Alemtuzumab induction in kidney transplant recipients

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Nephrology | 2007年 / 3卷 / 9期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：471 / 471
相关论文
共 50 条
  • [31] BK Virus Infection With Alemtuzumab Induction in Pediatric Kidney Transplant Recipients. A Single Center Experience
    Al-Uzri, A.
    Patel, T.
    Nolt, D.
    Jenkins, R.
    Iragorri, S.
    Rozansky, D.
    Munar, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 502 - 502
  • [32] Infectious Complications and Leukopenia Following Alemtuzumab or Antithymocyte Globulin Induction in De Novo Kidney Transplant Recipients
    Khamash, H.
    Mannon, R.
    Hanaway, M.
    Gaston, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 482 - 482
  • [33] On the Incidence of Acute Rejection (AR) and Allograft Outcome in Kidney Transplant Recipients Using Alemtuzumab Induction.
    Abate, Mersema
    Vijay, Dhanya
    Nourbakhsh, Noureddin
    Miller, Frederick
    Suh, Heesuck
    Darras, Frank
    Nord, Edward
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 394 - 394
  • [34] LOW-DOSE ALEMTUZUMAB INDUCTION IN SENSITIZED KIDNEY TRANSPLANT RECIPIENTS - ALLOGRAFT SURVIVAL AND INFECTION RATES
    Berger, K.
    Althaus, K.
    Nadalin, S.
    Koenigsrainer, A.
    Heyne, N.
    Guthoff, M.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 25 - 25
  • [35] Comparing Outcomes between Alemtuzumab and Non-Alemtuzumab Induction in Kidney Allograft Recipients
    Orquiza, Michael H.
    Moore, Jack
    Africa, Joseph B.
    Ghasemian, Seyed R.
    Melancon, Joseph K.
    Light, Jimmy A.
    Tucker, Marvin
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 77 - 78
  • [36] Comparing Outcomes Between Alemtuzumab and Non-Alemtuzumab Induction in Kidney Allograft Recipients
    Orquiza, M. H.
    Moore, J.
    Africa, J. B.
    Ghasemian, S. R.
    Melancon, J. K.
    Tucker, M.
    Light, J. A.
    TRANSPLANTATION, 2012, 94 (10) : 877 - 877
  • [37] Opportunistic Viral Infections After Alemtuzumab Induction: Results From a Randomized Controlled Trial (RCT) Comparing Alemtuzumab and Basiliximab Induction in Kidney Transplant Recipients (KTRs).
    Cherukuri, A.
    Welberry-Smith, M.
    Saundh, B.
    Hale, A.
    Baker, R.
    TRANSPLANTATION, 2014, 98 : 536 - 536
  • [38] Opportunistic Viral Infections After Alemtuzumab Induction: Results From a Randomized Controlled Trial (RCT) Comparing Alemtuzumab and Basiliximab Induction in Kidney Transplant Recipients (KTRs)
    Cherukuri, A.
    Welberry-Smith, M.
    Saundh, B.
    Hale, A.
    Baker, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 536 - 536
  • [39] Patterns of acute rejection in kidney transplant recipients treated with alemtuzumab induction and steroid-free maintenance therapy
    Bingaman, Adam W.
    Palma-Vargas, Juan
    Ortiz, Jorge
    Foster, Preston
    Wright, Francis
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 321 - 321
  • [40] Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy
    Bosch, W.
    Poowanawittayakom, N.
    Chaikriangkrai, K.
    Mendez, J.
    Hellinger, W. C.
    Gonwa, T. A.
    Krishna, M.
    Pungpapong, S.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (01) : E33 - E39
12345